53 related articles for article (PubMed ID: 22099930)
1. Assessment of tumor budding in colorectal carcinoma: correlation with β-catenin nuclear expression.
El-Gendi S; Al-Gendi A
J Egypt Natl Canc Inst; 2011 Mar; 23(1):1-9. PubMed ID: 22099930
[TBL] [Abstract][Full Text] [Related]
2. Nuclear beta-catenin overexpression in metastatic sentinel lymph node is associated with synchronous liver metastasis in colorectal cancer.
Cheng H; Liang H; Qin Y; Liu Y
Diagn Pathol; 2011 Nov; 6():109. PubMed ID: 22053859
[TBL] [Abstract][Full Text] [Related]
3. Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors.
Nagayama S; Yamada E; Kohno Y; Aoyama T; Fukukawa C; Kubo H; Watanabe G; Katagiri T; Nakamura Y; Sakai Y; Toguchida J
Cancer Sci; 2009 Mar; 100(3):405-12. PubMed ID: 19134005
[TBL] [Abstract][Full Text] [Related]
4. Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer.
Luo YH; Yan ZC; Liu JY; Li XY; Yang M; Fan J; Huang B; Ma CG; Chang XN; Nie X
World J Gastroenterol; 2024 Jan; 30(2):158-169. PubMed ID: 38312121
[TBL] [Abstract][Full Text] [Related]
5. High KRT17 expression in tumour budding indicates immunologically 'hot' tumour budding and predicts good survival in patients with colorectal cancer.
Liang W; Jie H; Xie H; Zhou Y; Li W; Huang L; Liang Z; Liu H; Zheng X; Zeng Z; Kang L
Clin Transl Immunology; 2024; 13(3):e1495. PubMed ID: 38433762
[TBL] [Abstract][Full Text] [Related]
6. Expression of Epidermal Growth Factor Receptor (EGFR) and β-catenin in Colorectal Carcinoma and its Correlation with Tumor Grade and Stage.
Yadav A; Singh S; Sarin N; Pujani M; Wadhwa R; Sarohi M; Ab A
Indian J Surg Oncol; 2023 Dec; 14(4):758-764. PubMed ID: 38187861
[TBL] [Abstract][Full Text] [Related]
7. Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.
Mehta A; Goswami M; Sinha R; Dogra A
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2447-2453. PubMed ID: 30255698
[TBL] [Abstract][Full Text] [Related]
8. EBP50 Depletion and Nuclear β-Catenin Accumulation Engender Aggressive Behavior of Colorectal Carcinoma through Induction of Tumor Budding.
Itou T; Ishibashi Y; Oguri Y; Hashimura M; Yokoi A; Harada Y; Fukagawa N; Hayashi M; Ono M; Kusano C; Saegusa M
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201610
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cyclin D1 activity in tumors and tumor budding and its prognostic significance in tumor budding in colorectal carcinomas.
Coban G; Arici DS; Tekden BC; Yildiz P; Kiran T; Toluk Ö; Turk HM; Şahin N
Indian J Pathol Microbiol; 2024 Jun; ():. PubMed ID: 38847197
[TBL] [Abstract][Full Text] [Related]
10. Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer.
Rosova B; Proks J; Filipova A; Hadzi Nikolov D; Chloupkova R; Richter I; Szabo A; Rozsypalova A; Matej R; Melichar B; Buchler T; Dvorak J
Neoplasma; 2023 Dec; 70(6):796-803. PubMed ID: 38247336
[TBL] [Abstract][Full Text] [Related]
11. Tumor Budding Assessment in Colorectal Carcinoma: Normalization Revisited.
Cyr DP; Pun C; Shivji S; Mitrovic B; Duan K; Tomin R; Sari A; Brar A; Zerhouni S; Brar MS; Kennedy ED; Swallow CJ; Kirsch R; Conner JR
Am J Surg Pathol; 2024 Mar; 48(3):251-265. PubMed ID: 38108373
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological evaluation of tumor budding in the oncological progression of colorectal cancer.
Giordano PG; Díaz Zelaya AG; Aguilera Molina YY; Taboada Mostajo NO; Ajete Ramos Y; Ortega García R; Peralta de Michelis E; Meneu Díaz JC
Med Clin (Barc); 2024 May; ():. PubMed ID: 38697893
[TBL] [Abstract][Full Text] [Related]
13. The Relationship between Tumor Budding and Tumor Deposits in Patients with Stage III Colorectal Carcinoma.
Bilić Z; Zovak M; Glavčić G; Mužina D; Ibukić A; Košec A; Tomas D; Demirović A
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731112
[No Abstract] [Full Text] [Related]
14. Prognostic evaluation of cancer associated fibrosis and tumor budding in colorectal cancer.
Khan AA; Malik S; Jacob S; Aden D; Ahuja S; Zaheer S; Ranga S
Pathol Res Pract; 2023 Aug; 248():154587. PubMed ID: 37315399
[TBL] [Abstract][Full Text] [Related]
15. Survivin, β-catenin, and ki-67 immunohistochemical expression in canine perivascular wall tumors: Preliminary assessment of prognostic significance.
Godizzi F; Armando F; Boracchi P; Avallone G; Stefanello D; Ferrari R; Chiti LE; Cappelleri A; Zamboni C; Dell'Aere S; Corradi A; Roccabianca P
Vet Pathol; 2024 May; ():3009858241246981. PubMed ID: 38727195
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Tumor Budding for Early Breast Cancer.
Silva DJ; Miranda G; Amaro T; Salgado M; Mesquita A
Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001907
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of tumor budding and EMT in periampullary adenocarcinoma: a quantitative approach.
Kocsmár É; Lotz G; Kiss A; Hoerner M; Petrova E; Freudenberg N; Csanádi Á; Kulemann B; Werner M; Bronsert P; Wellner UF
J Cancer; 2020; 11(22):6474-6483. PubMed ID: 33046968
[TBL] [Abstract][Full Text] [Related]
18. Adapting SAM to Histopathology Images for Tumor Bud Segmentation in Colorectal Cancer.
Su Z; Chen W; Annem S; Sajjad U; Rezapour M; Frankel WL; Gurcan MN; Niazi MKK
Proc SPIE Int Soc Opt Eng; 2024 Feb; 12933():. PubMed ID: 38765185
[TBL] [Abstract][Full Text] [Related]
19. Neighboring macrophage-induced alteration in the phenotype of colorectal cancer cells in the tumor budding area.
Kawamura I; Ohe R; Suzuki K; Kabasawa T; Kitaoka T; Takahara D; Kono M; Uchiyama N; Musha H; Futakuchi M; Motoi F
Cancer Cell Int; 2024 Mar; 24(1):107. PubMed ID: 38486225
[TBL] [Abstract][Full Text] [Related]
20. Pediatric NCOA3-rearranged low-grade fibroblastic tumor with nuclear beta-catenin immunoreactivity.
Malik F; Furtado LV; Eldomery MK; Shi Z; Koo SC
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23223. PubMed ID: 38340030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
